Chemomab

Disease targeting mAbs for immune-mediated and fibrotic disorders

placeTel Aviv, Tel Aviv, Israel calendar_todayFounded 2011 groups37 employees language chemomab.com

Registered entities

Innovation

5 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 261 times.

YearFilings
20151
20161
20173
20182
20192
20201
20213
20223
20234
20242

Social engagement

Social engagement: 2.8K social following, 9 posts in the last 12 months — above the industry median.

Investor mix

7 investors on record; lead investors include Orbimed, Array.

Investor typeCountShare
Venture capital457%
Private equity229%
Other / undisclosed114%

Recent activity

5 May 2026
Event
Diving Disease Week 26®
17 Feb 2026
Event
Oppenheimer 36th Annual Healthcare Life Sciences Conference
27 Jan 2026
Event
6th Annual Liver Connect Conference
Coming soon